AAAAAA

   
Results: 1-12 |
Results: 12
The prognostic value of molecular marker analysis in patients treated withtrimodality therapy for esophageal cancer
Authors: Harpole, DH Moore, MB Herndon, JE Aloia, T D'Amico, TA Sporn, T Parr, A Linoila, I Allegra, C
Citation: Dh. Harpole et al., The prognostic value of molecular marker analysis in patients treated withtrimodality therapy for esophageal cancer, CLIN CANC R, 7(3), 2001, pp. 562-569
Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer
Authors: Marom, EM Aloia, TA Moore, MB Hara, M Herndon, JE Harpole, DH Goodman, PC Patz, EF
Citation: Em. Marom et al., Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 99-107
Predicting the sites of metastases from lung cancer using molecular biologic markers
Authors: D'Amico, TA Aloia, TA Moore, MBH Conlon, DH Herndon, JE Kinch, MS Harpole, DH
Citation: Ta. D'Amico et al., Predicting the sites of metastases from lung cancer using molecular biologic markers, ANN THORAC, 72(4), 2001, pp. 1144-1148
Tumor marker expression is predictive of survival in patients with esophageal cancer
Authors: Aloia, TA Harpole, DH Reed, CE Allegra, C Moore, MBH Herndon, JE D'Amico, TA
Citation: Ta. Aloia et al., Tumor marker expression is predictive of survival in patients with esophageal cancer, ANN THORAC, 72(3), 2001, pp. 859-866
Noninvasive clinical staging modalities for lung cancer
Authors: Lau, CL Harpole, DH
Citation: Cl. Lau et Dh. Harpole, Noninvasive clinical staging modalities for lung cancer, SEM SURG ON, 18(2), 2000, pp. 116-123
Correlation of tumor size and survival in patients with stage IA non-smallcell lung cancer
Authors: Patz, EF Rossi, S Harpole, DH Herndon, JE Goodman, PC
Citation: Ef. Patz et al., Correlation of tumor size and survival in patients with stage IA non-smallcell lung cancer, CHEST, 117(6), 2000, pp. 1568-1571
Expression of human telomerase subunit genes in primary lung cancer and its clinical significance - Invited commentary
Authors: Harpole, DH
Citation: Dh. Harpole, Expression of human telomerase subunit genes in primary lung cancer and its clinical significance - Invited commentary, ANN THORAC, 70(2), 2000, pp. 405-406
Molecular biologic substaging of stage I lung cancer according to gender and histology
Authors: D'Amico, TA Aloia, TA Moor, MBH Herndon, JE Brooks, KR Lau, CL Harpole, DH
Citation: Ta. D'Amico et al., Molecular biologic substaging of stage I lung cancer according to gender and histology, ANN THORAC, 69(3), 2000, pp. 882-886
Lung neoplasms
Authors: Lau, CL Harpole, DH
Citation: Cl. Lau et Dh. Harpole, Lung neoplasms, SURGERY: BASIC SCIENCE AND CLINICAL EVIDENCE, 2000, pp. 1189-1216
Prognostic models of thirty-day mortality and morbidity after major pulmonary resection
Authors: Harpole, DH DeCamp, MM Daley, J Hur, K Oprian, CA Henderson, WG Khuri, SF
Citation: Dh. Harpole et al., Prognostic models of thirty-day mortality and morbidity after major pulmonary resection, J THOR SURG, 117(5), 1999, pp. 969-979
A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
Authors: D'Amico, TA Massey, M Herndon, JE Moore, MB Harpole, DH
Citation: Ta. D'Amico et al., A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers, J THOR SURG, 117(4), 1999, pp. 736-742
Cognitive decline after major noncardiac operations: A preliminary prospective study
Authors: Grichnik, KP Ijsselmuiden, AJJ D'Amico, TA Harpole, DH White, WD Blumenthal, JA Newman, MF
Citation: Kp. Grichnik et al., Cognitive decline after major noncardiac operations: A preliminary prospective study, ANN THORAC, 68(5), 1999, pp. 1786-1791
Risultati: 1-12 |